Use of Partial Area under the Curve Metrics to Assess Bioequivalence of Methylphenidate Multiphasic Modified Release Formulations

被引:19
作者
Stier, Ethan M. [1 ]
Davit, Barbara M. [1 ]
Chandaroy, Parthapratim [1 ]
Chen, Mei-Ling [2 ]
Fourie-Zirkelbach, Jeanne [3 ]
Jackson, Andre [3 ]
Kim, Stephanie
Lionberger, Robert
Mehta, Mehul [3 ]
Uppoor, Ramana S. [3 ]
Wang, Yaning [3 ]
Yu, Lawrence
Conner, Dale P. [1 ]
机构
[1] US FDA, Div Bioequivalence, Off Gener Drugs, Rockville, MD 20855 USA
[2] US FDA, Off Pharmaceut Sci, Silver Spring, MD USA
[3] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
attention deficit hyperactivity disorder; bioequivalence; generic drugs; methylphenidate; pAUC; CHILDREN;
D O I
10.1208/s12248-012-9397-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:925 / 926
页数:2
相关论文
共 7 条
[1]  
[Anonymous], 2010, M ADV COMM PHARM SCI
[2]  
[Anonymous], FDA M ADV COMM PHARM
[3]   Using Partial Area for Evaluation of Bioavailability and Bioequivalence [J].
Chen, Mei-Ling ;
Davit, Barbara ;
Lionberger, Robert ;
Wahba, Zakaria ;
Ahn, Hae-Young ;
Yu, Lawrence X. .
PHARMACEUTICAL RESEARCH, 2011, 28 (08) :1939-1947
[4]  
Chen ML, 2010, AAPS J, V12, P371, DOI DOI 10.1208/S12248-010-9201-5
[5]  
SWANSON J, 1978, PEDIATRICS, V61, P21
[6]   A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (The COMACS study) [J].
Swanson, JM ;
Wigal, SB ;
Wigal, T ;
Sonuga-Barke, EJS ;
Greenhill, LL ;
Biederman, J ;
Kollins, S ;
Nguyen, AS ;
DeCory, HH ;
Dirksen, SJH ;
Hatch, SJ .
PEDIATRICS, 2004, 113 (03) :E206-E216
[7]  
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research (CDER), GUID IND BIOAV BIOEQ